<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37511673</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>Precision Medicine for More Oxygen (P4O2)-Study Design and First Results of the Long COVID-19 Extension.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1060</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm13071060</ELocationID><Abstract><AbstractText><b>Introduction</b>: The coronavirus disease 2019 (COVID-19) pandemic has led to the death of almost 7 million people, however, with a cumulative incidence of 0.76 billion, most people survive COVID-19. Several studies indicate that the acute phase of COVID-19 may be followed by persistent symptoms including fatigue, dyspnea, headache, musculoskeletal symptoms, and pulmonary functional-and radiological abnormalities. However, the impact of COVID-19 on long-term health outcomes remains to be elucidated. <b>Aims</b>: The Precision Medicine for more Oxygen (P4O2) consortium COVID-19 extension aims to identify long COVID patients that are at risk for developing chronic lung disease and furthermore, to identify treatable traits and innovative personalized therapeutic strategies for prevention and treatment. This study aims to describe the study design and first results of the P4O2 COVID-19 cohort. <b>Methods</b>: The P4O2 COVID-19 study is a prospective multicenter cohort study that includes nested personalized counseling intervention trial. Patients, aged 40-65 years, were recruited from outpatient post-COVID clinics from five hospitals in The Netherlands. During study visits at 3-6 and 12-18 months post-COVID-19, data from medical records, pulmonary function tests, chest computed tomography scans and biological samples were collected and questionnaires were administered. Furthermore, exposome data was collected at the patient's home and state-of-the-art imaging techniques as well as multi-omics analyses will be performed on collected data. <b>Results</b>: 95 long COVID patients were enrolled between May 2021 and September 2022. The current study showed persistence of clinical symptoms and signs of pulmonary function test/radiological abnormalities in post-COVID patients at 3-6 months post-COVID. The most commonly reported symptoms included respiratory symptoms (78.9%), neurological symptoms (68.4%) and fatigue (67.4%). Female sex and infection with the Delta, compared with the Beta, SARS-CoV-2 variant were significantly associated with more persisting symptom categories. <b>Conclusions</b>: The P4O2 COVID-19 study contributes to our understanding of the long-term health impacts of COVID-19. Furthermore, P4O2 COVID-19 can lead to the identification of different phenotypes of long COVID patients, for example those that are at risk for developing chronic lung disease. Understanding the mechanisms behind the different phenotypes and identifying these patients at an early stage can help to develop and optimize prevention and treatment strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baalbaki</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blankestijn</LastName><ForeName>Jelle M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0009-0006-2047-0888</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdel-Aziz</LastName><ForeName>Mahmoud I</ForeName><Initials>MI</Initials><Identifier Source="ORCID">0000-0001-9263-7137</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Backer</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Fluidda, Groeningenlei 132, 2550 Kontich, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bazdar</LastName><ForeName>Somayeh</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8266-8156</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beekers</LastName><ForeName>In&#xe9;s</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>ORTEC BV, Department of Health, Houtsingel 5, 2719 EA Zoetermeer, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beijers</LastName><ForeName>Rosanne J H C G</ForeName><Initials>RJHCG</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NUTRIM School of Nutrition and Translational Research in Metabolism, 6200 MD Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Bergh</LastName><ForeName>Joop P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, VieCuri Medical Center, 5912 BL Venlo, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloemsma</LastName><ForeName>Lizan D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogaard</LastName><ForeName>Harm Jan</ForeName><Initials>HJ</Initials><Identifier Source="ORCID">0000-0001-5371-0346</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Bragt</LastName><ForeName>Job J M H</ForeName><Initials>JJMH</Initials><Identifier Source="ORCID">0000-0002-7133-955X</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Brink</LastName><ForeName>Vera</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charbonnier</LastName><ForeName>Jean Paul</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Thirona, Toernooiveld 300, 6525 EC Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cornelissen</LastName><ForeName>Merel E B</ForeName><Initials>MEB</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dagelet</LastName><ForeName>Yennece</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Breathomix B.V., Bargelaan 200, 2333 CW Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Elin Haf</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Aparito Netherlands B.V., Galileiweg 8, BioPartner 3 Building, 2333 BD Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Does</LastName><ForeName>Anne M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Downward</LastName><ForeName>George S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Department of Environmental Epidemiology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, 3584 CL Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Drunen</LastName><ForeName>Cornelis M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gach</LastName><ForeName>Debbie</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NUTRIM School of Nutrition and Translational Research in Metabolism, 6200 MD Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geelhoed</LastName><ForeName>J J Miranda</ForeName><Initials>JJM</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glastra</LastName><ForeName>Jorrit</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Quantib-U, Westblaak 106, 3012 KM Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golebski</LastName><ForeName>Kornel</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heijink</LastName><ForeName>Irene H</ForeName><Initials>IH</Initials><Identifier Source="ORCID">0000-0002-1260-8932</Identifier><AffiliationInfo><Affiliation>Department of Pulmonology, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department Pathology &amp; Medical Biology, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holtjer</LastName><ForeName>Judith C S</ForeName><Initials>JCS</Initials><AffiliationInfo><Affiliation>Department of Environmental Epidemiology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, 3584 CL Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holverda</LastName><ForeName>Sebastiaan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Longfonds, Stationsplein 125, 3818 LE Amersfoort, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houweling</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Environmental Epidemiology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, 3584 CL Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>John J L</ForeName><Initials>JJL</Initials><Identifier Source="ORCID">0000-0003-2249-5668</Identifier><AffiliationInfo><Affiliation>ORTEC BV, Department of Health, Houtsingel 5, 2719 EA Zoetermeer, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonker</LastName><ForeName>Ren&#xe9;e</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kos</LastName><ForeName>Renate</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9895-9636</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langen</LastName><ForeName>Ramon C J</ForeName><Initials>RCJ</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Lee</LastName><ForeName>Ivo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Spaarne Hospital, 2134 TM Hoofddorp, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leliveld</LastName><ForeName>Asabi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamed Hoesein</LastName><ForeName>Firdaus A A</ForeName><Initials>FAA</Initials><AffiliationInfo><Affiliation>Department of Radiology, University Medical Center Utrecht and Utrecht University, 3508 GA Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neerincx</LastName><ForeName>Anne H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noij</LastName><ForeName>Lieke</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4528-6351</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olsson</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Smartfish AS, Oslo Science Park, Gaustadall&#xe9;en 21, 0349 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van de Pol</LastName><ForeName>Marianne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pouwels</LastName><ForeName>Simon D</ForeName><Initials>SD</Initials><Identifier Source="ORCID">0000-0001-7345-8061</Identifier><AffiliationInfo><Affiliation>Department of Pulmonology, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department Pathology &amp; Medical Biology, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rolink</LastName><ForeName>Emiel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Long Alliantie Nederland, Address Stationsplein 125, 3818 LE Amersfoort, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rutgers</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Longfonds, Stationsplein 125, 3818 LE Amersfoort, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x218;ahin</LastName><ForeName>Havva</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaminee</LastName><ForeName>Daphne</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schols</LastName><ForeName>Annemie M W J</ForeName><Initials>AMWJ</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NUTRIM School of Nutrition and Translational Research in Metabolism, 6200 MD Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuurman</LastName><ForeName>Lisanne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NUTRIM School of Nutrition and Translational Research in Metabolism, 6200 MD Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slingers</LastName><ForeName>Gitte</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Breathomix B.V., Bargelaan 200, 2333 CW Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smeenk</LastName><ForeName>Olie</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Sodaq, Bussumerstraat 34, 1211 BL Hilversum, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sondermeijer</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Spaarne Hospital, 2134 TM Hoofddorp, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skipp</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>TopMD Precision Medicine Ltdincorporated, Southhampton SO45 3PN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamarit</LastName><ForeName>Marisca</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Breathomix B.V., Bargelaan 200, 2333 CW Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verkouter</LastName><ForeName>Inge</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>ORTEC BV, Department of Health, Houtsingel 5, 2719 EA Zoetermeer, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vermeulen</LastName><ForeName>Roel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Environmental Epidemiology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, 3584 CL Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Vries</LastName><ForeName>Rianne</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Breathomix B.V., Bargelaan 200, 2333 CW Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weersink</LastName><ForeName>Els J M</ForeName><Initials>EJM</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van de Werken</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0007-4230-1863</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Wit-van Wijck</LastName><ForeName>Yolanda</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Stewart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Philips GmbH Innovative Technologies, 4646 AG Eindhoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nossent</LastName><ForeName>Esther J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maitland-van der Zee</LastName><ForeName>Anke H</ForeName><Initials>AH</Initials><Identifier Source="ORCID">0000-0002-0414-3442</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>P4O2 consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>LSHM20104; LSHM20068</GrantID><Agency>Health Holland</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">infectious disease</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">precision medicine</Keyword><Keyword MajorTopicYN="N">prospective observational cohort study</Keyword></KeywordList><CoiStatement>M.I. Abdel-Aziz has nothing to declare. N. Baalbaki has nothing to declare. S. Bazdar has nothing to declare. I. Beekers has nothing to declare. R.J.H.C.G. Beijers has nothing to declare. J.M. Blankestijn has nothing to declare. M. van de Berge has nothing to declare. J.J.P. van den Bergh has a research funding from UCB and Amgen (outside P4O2). L.D. Bloemsma has nothing to declare. H.J. Bogaard received a Grant support Ferrer (Janssen, MSD). C.D.C. Born has nothing to declare. M.S.G.M. Bracke is the Co-founder of Clear. M.E.B. Cornelissen has nothing to declare. J.W.F. Dagelet received personal fees from the start-up company Breathomix BV. A.M. van der Does has nothing to declare. G.S. Downward has nothing to declare. C.M. van Drunen has nothing to declare. J.W. Duitman will receive financial support from Boehringer and Abbvie for the P4O2 ILD cohort. D. Gach has nothing to declare. J. Garssen has nothing to declare. J.J.M. Geelhoed has nothing to declare. J. Glastra is employee at Quantib. K. Golebski has nothing to declare. I.H. Heijink has a Research grant from Boeheringer Ingelheim outside the scope of the submitted work. P.S. Hiemstra has nothing to declare. J.C.S. Holtjer has nothing to declare. S. Holverda has nothing to declare. L. Houweling has nothing to declare. J.J.L. Jacobs has nothing to declare. R. Jonker has nothing to declare. P.J.M. Kuks has nothing to declare. A.K.A.L. Kwee has nothing to declare. R.C.J. Langen has nothing to declare. A.H. Maitland-van der Zee has received research grants outside the submitted work from GSK, Boehringer Ingelheim, AbbVie and Vertex, she is the PI of P4O2 (Precision Medicine for more Oxygen), a public private partnership co-funded by Health~Holland involving many private partners that contribute in-cash and/or in-kind (Aparito, Boehringer Ingelheim, Breathomix, Clear, Danone Nutricia Research, Fluidda, MonitAir, Ncardia, Ortec Logiqcare, Philips, Quantib-U, RespiQ, Roche, Smartfish, SODAQ, Thirona, TopMD and Novartis), and she has served in advisory boards for AstraZeneca, GSK, and Boehringer Ingelheim with money paid to her institution. M.M.A. Van Melle is advisor and previous researcher in conquest and prevail research project, funded by Optimum Patient Care and AstraZeneca.P. Moeskops is employee at Quantib. F.A.A. Mohamed Hoesein has nothing to declare. J. Mosayebi Amroabadi has nothing to declare. L. Noij has nothing to declare. E.J. Nossent has speaker fees for lectures and educational events (Janssen, Bayer/MSD, Astra Zeneca) United Therapeutics/Ferrer, Boehringer Ingelheim B.V., Chiesi. J. Olsson is employed at Smartfish which produce Remune (which is used in P4O2 as oral nutrition product). J. Otker has nothing to declare. S.D. Pouwels has an affiliation. B.R. Rae has nothing to declare. L.B. Richards has nothing to declare. A. Rodriguez Ruiz has nothing to declare. D.W. Schaminee has nothing to declare. A.M.W.J. Schols has nothing to declare. L.T. Schuurman has nothing to declare. S. Shahbazi Khamas has nothing to declare. G. Slingers receives personal fees from the company Breathomix BV. M. Tamarit receives personal fees from the company Breathomix BV. G.F. Vasse has nothing to declare. I. Verkouter has nothing to declare. R. de Vries receives personal fees and has a substantial interest in the company Breathomix BV. Y. de Wit-van Wijck has nothing to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37511673</ArticleId><ArticleId IdType="pmc">PMC10381397</ArticleId><ArticleId IdType="doi">10.3390/jpm13071060</ArticleId><ArticleId IdType="pii">jpm13071060</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dixon B.E., Wools-Kaloustian K., Fadel W.F., Duszynski T.J., Yiannoutsos C., Halverson P.K., Menachemi N. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study. Public Glob. Health. 2020;16:e0241875. doi: 10.1371/journal.pone.0241875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241875</ArticleId><ArticleId IdType="pmc">PMC7990210</ArticleId><ArticleId IdType="pubmed">33760821</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobin M.J., Laghi F., Jubran A. Why COVID-19 Silent Hypoxemia Is Baffling to Physicians. Am. J. Respir. Crit. Care Med. 2020;202:356&#x2013;360. doi: 10.1164/rccm.202006-2157CP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202006-2157CP</ArticleId><ArticleId IdType="pmc">PMC7397783</ArticleId><ArticleId IdType="pubmed">32539537</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., Li F. Cell Entry Mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. USA. 2020;117:11727&#x2013;11734. doi: 10.1073/pnas.2003138117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003138117</ArticleId><ArticleId IdType="pmc">PMC7260975</ArticleId><ArticleId IdType="pubmed">32376634</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M., Lely A., Navis G., van Goor H. Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis. J. Pathol. 2004;203:631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-Month Consequences of COVID-19 in Patients Discharged from Hospital: A Cohort Study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., for the Gemelli against COVID-19 Post-Acute Care Study Group Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. World Health Organization; Geneva, Switzerland: 2021.</Citation></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, Co-Occurrence, and Evolution of Long-COVID Features: A 6-Month Retrospective Cohort Study of 273,618 Survivors of COVID-19. PLoS Med. 2021;18:e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-Term and Long-Term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  At Least 17 Million People in the WHO European Region Experienced Long COVID in the First Two Years of the Pandemic; Millions May Have to Live with It for Years to Come.  [(accessed on 6 June 2022)].  Available online:  https://www.who.int/europe/news/item/13-09-2022-at-least-17-million-people-in-the-who-european-region-experienced-long-covid-in-the-first-two-years-of-the-pandemic--millions-may-have-to-live-with-it-for-years-to-come.</Citation></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., McDonald D., Magedson A., Wolf C.R., Chu H.Y. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., Houben-Wilke S., Burtin C., Posthuma R., Franssen F.M.E., et al. Persistent Symptoms 3 Months after a SARS-CoV-2 Infection: The Post-COVID-19 Syndrome? ERJ Open Res. 2020;6:00542&#x2013;02020. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long Covid&#x2014;Mechanisms, Risk Factors, and Management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannister B.A. Post-Infectious Disease Syndrome. Postgrad. Med. J. 1988;64:559&#x2013;567. doi: 10.1136/pgmj.64.753.559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.64.753.559</ArticleId><ArticleId IdType="pmc">PMC2428896</ArticleId><ArticleId IdType="pubmed">3074289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E., Malorni W. Long COVID: To Investigate Immunological Mechanisms and Sex/Gender Related Aspects as Fundamental Steps for Tailored Therapy. Eur. Respir. J. 2022;59:2102245. doi: 10.1183/13993003.02245-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02245-2021</ArticleId><ArticleId IdType="pmc">PMC8462012</ArticleId><ArticleId IdType="pubmed">34531277</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-Acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B., Boustani K., Ogger P.P., Papadaki A., Tonkin J., Orton C.M., Ghai P., Suveizdyte K., Hewitt R.J., Desai S.R., et al. Immuno-Proteomic Profiling Reveals Aberrant Immune Cell Regulation in the Airways of Individuals with Ongoing Post-COVID-19 Respiratory Disease. Immunity. 2022;55:542&#x2013;556.e5. doi: 10.1016/j.immuni.2022.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.017</ArticleId><ArticleId IdType="pmc">PMC8789571</ArticleId><ArticleId IdType="pubmed">35151371</ArticleId></ArticleIdList></Reference><Reference><Citation>Ero&#x11f;lu &#x130;., Ero&#x11f;lu B.&#xc7;., G&#xfc;ven G.S. Altered Tryptophan Absorption and Metabolism Could Underlie Long-Term Symptoms in Survivors of Coronavirus Disease 2019 (COVID-19) Nutrition. 2021;90:111308. doi: 10.1016/j.nut.2021.111308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2021.111308</ArticleId><ArticleId IdType="pmc">PMC8087860</ArticleId><ArticleId IdType="pubmed">34111831</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemeth H., Toldi J., Vecsei L. Role of Kynurenines in the Central and Peripherial Nervous Systems. CNR. 2005;2:249&#x2013;260. doi: 10.2174/1567202054368326.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567202054368326</ArticleId><ArticleId IdType="pubmed">16181118</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  Exposome and Exposomics | NIOSH | CDC.  [(accessed on 22 June 2022)]; Available online:  https://www.cdc.gov/niosh/topics/exposome/default.html.</Citation></Reference><Reference><Citation>La Rosa P.S., Brooks J.P., Deych E., Boone E.L., Edwards D.J., Wang Q., Sodergren E., Weinstock G., Shannon W.D. Hypothesis Testing and Power Calculations for Taxonomic-Based Human Microbiome Data. PLoS ONE. 2012;7:e52078. doi: 10.1371/journal.pone.0052078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052078</ArticleId><ArticleId IdType="pmc">PMC3527355</ArticleId><ArticleId IdType="pubmed">23284876</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyamundanda G., Gormley I.C., Fan Y., Gallagher W.M., Brennan L. MetSizeR: Selecting the Optimal Sample Size for Metabolomic Studies Using an Analysis Based Approach. BMC Bioinform. 2013;14:338. doi: 10.1186/1471-2105-14-338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-338</ArticleId><ArticleId IdType="pmc">PMC4222287</ArticleId><ArticleId IdType="pubmed">24261687</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaise B.J., Correia G., Tin A., Young J.H., Vergnaud A.-C., Lewis M., Pearce J.T.M., Elliott P., Nicholson J.K., Holmes E., et al. Power Analysis and Sample Size Determination in Metabolic Phenotyping. Anal. Chem. 2016;88:5179&#x2013;5188. doi: 10.1021/acs.analchem.6b00188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.6b00188</ArticleId><ArticleId IdType="pubmed">27116637</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . WHO R&amp;D Blueprint Novel Coronavirus COVID-19 Therapeutic Trial Synopsis. World Health Organization; Geneva, Switzerland: 2020.</Citation></Reference><Reference><Citation>RIVM  Variants of the Coronavirus SARS-CoV-2.  [(accessed on 30 June 2022)].  Available online:  https://www.rivm.nl/en/coronavirus-covid-19/virus/variants.</Citation></Reference><Reference><Citation>CDC  Long COVID or Post-COVID Conditions.  [(accessed on 6 June 2022)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Ghayda R.A., Lee K.H., Kim J.S., Lee S., Hong S.H., Kim K.S., Kim K.E., Seok J., Kim H., Seo J., et al. Chest CT Abnormalities in COVID-19: A Systematic Review. Int. J. Med. Sci. 2021;18:3395&#x2013;3402. doi: 10.7150/ijms.50568.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.50568</ArticleId><ArticleId IdType="pmc">PMC8436104</ArticleId><ArticleId IdType="pubmed">34522166</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanne J.P., Little B.P., Schulte J.J., Haramati A., Haramati L.B. Long-Term Lung Abnormalities Associated with COVID-19 Pneumonia. Radiology. 2022;306:221806. doi: 10.1148/radiol.221806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.221806</ArticleId><ArticleId IdType="pmc">PMC9462591</ArticleId><ArticleId IdType="pubmed">36040336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemh&#xf6;fer C., Sturm C., Loudovici-Krug D., Best N., Gutenbrunner C. The Impact of Post-COVID-Syndrome on Functioning&#x2014;Results from a Community Survey in Patients after Mild and Moderate SARS-CoV-2-Infections in Germany. J. Occup. Med. Toxicol. 2021;16:45. doi: 10.1186/s12995-021-00337-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12995-021-00337-9</ArticleId><ArticleId IdType="pmc">PMC8495185</ArticleId><ArticleId IdType="pubmed">34620202</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson K.B., Rao M., Bonilla H., Subramanian A., Hack I., Madrigal M., Singh U., Jagannathan P., Grant P. Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale During a Global Pandemic. Clin. Infect. Dis. 2021;73:e826&#x2013;e829. doi: 10.1093/cid/ciab103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab103</ArticleId><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis M.M. Flexibility for Specificity. Science. 2015;347:371&#x2013;372. doi: 10.1126/science.aaa5082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa5082</ArticleId><ArticleId IdType="pubmed">25613876</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Hamilton F.W., Milne A., Morley A.J., Viner J., Attwood M., Noel A., Gunning S., Hatrick J., Hamilton S., et al. Patient Outcomes after Hospitalisation with COVID-19 and Implications for Follow-up: Results from a Prospective UK Cohort. Thorax. 2021;76:399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali S.T., Kang A.K., Patel T.R., Clark J.R., Perez-Giraldo G.S., Orban Z.S., Lim P.H., Jimenez M., Graham E.L., Batra A., et al. Evolution of Neurologic Symptoms in Non-hospitalized COVID-19 &#x201c;Long Haulers&#x201d;. Ann. Clin. Transl. Neurol. 2022;9:950&#x2013;961. doi: 10.1002/acn3.51570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51570</ArticleId><ArticleId IdType="pmc">PMC9268866</ArticleId><ArticleId IdType="pubmed">35607826</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., Barbanotti D., Castoldi R., Mul&#xe8; G., Augello M., Mondatore D., Allegrini M., Cona A., et al. Female Gender Is Associated with Long COVID Syndrome: A Prospective Cohort Study. Clin. Microbiol. Infect. 2022;28:611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Dryden M., Mudara C., Vika C., Blumberg L., Mayet N., Cohen C., Tempia S., Parker A., Nel J., Perumal R., et al. Post-COVID-19 Condition 3 Months after Hospitalisation with SARS-CoV-2 in South Africa: A Prospective Cohort Study. Lancet Glob. Health. 2022;10:e1247&#x2013;e1256. doi: 10.1016/S2214-109X(22)00286-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(22)00286-8</ArticleId><ArticleId IdType="pmc">PMC9363040</ArticleId><ArticleId IdType="pubmed">35961348</ArticleId></ArticleIdList></Reference><Reference><Citation>Pel&#xe0; G., Goldoni M., Solinas E., Cavalli C., Tagliaferri S., Ranzieri S., Frizzelli A., Marchi L., Mori P.A., Majori M., et al. Sex-Related Differences in Long-COVID-19 Syndrome. J. Women&#x2019;s Health. 2022;31:620&#x2013;630. doi: 10.1089/jwh.2021.0411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2021.0411</ArticleId><ArticleId IdType="pubmed">35333613</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and Predictors of Long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>the European Network on ME/CFS (EUROMENE) Rasa S., Nora-Krukle Z., Henning N., Eliassen E., Shikova E., Harrer T., Scheibenbogen C., Murovska M., Prusty B.K. Chronic Viral Infections in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) J. Transl. Med. 2018;16:268. doi: 10.1186/s12967-018-1644-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C., Freitag H., Meyer-Arndt L., Wittke K., Hanitsch L.G., Zoller T., Steinbeis F., Haffke M., Rudolf G., Heidecker B., et al. A Prospective Observational Study of Post-COVID-19 Chronic Fatigue Syndrome Following the First Pandemic Wave in Germany and Biomarkers Associated with Symptom Severity. Nat. Commun. 2022;13:5104. doi: 10.1038/s41467-022-32507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M., Soddu D., Balbo P.E., Baricich A., Zeppegno P., Avanzi G.C., Baldon G., Bartolomei G., Battaglia M., Battistini S., et al. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge. JAMA Netw Open. 2021;4:e2036142. doi: 10.1001/jamanetworkopen.2020.36142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36142</ArticleId><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn&#xfa;sd&#xf3;ttir I., Lovik A., Unnarsd&#xf3;ttir A.B., McCartney D., Ask H., K&#xf5;iv K., Christoffersen L.A.N., Johnson S.U., Hauksd&#xf3;ttir A., Fawns-Ritchie C., et al. Acute COVID-19 Severity and Mental Health Morbidity Trajectories in Patient Populations of Six Nations: An Observational Study. Lancet Public Health. 2022;7:e406&#x2013;e416. doi: 10.1016/S2468-2667(22)00042-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(22)00042-1</ArticleId><ArticleId IdType="pmc">PMC8920517</ArticleId><ArticleId IdType="pubmed">35298894</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimbos Instituut  Neerslachtiger, Meer Slaapproblemen En Gedachten Aan de Dood Door Corona.  [(accessed on 7 July 2022)].  Available online:  https://www.trimbos.nl/actueel/nieuws/neerslachtiger-meer-slaapproblemen-en-gedachten-aan-de-dood-door-corona/</Citation></Reference><Reference><Citation>Centraal Bureau voor de Statistiek  Meer Volwassenen Met Ernstig Overgewicht Tevreden Met Gewicht.  [(accessed on 8 July 2022)].  Available online:  https://www.cbs.nl/nl-nl/nieuws/2021/34/meer-volwassenen-met-ernstig-overgewicht-tevreden-met-gewicht.</Citation></Reference><Reference><Citation>Venkatakrishnan A.J., Pawlowski C., Zemmour D., Hughes T., Anand A., Berner G., Kayal N., Puranik A., Conrad I., Bade S., et al. Mapping Each Pre-Existing Condition&#x2019;s Association to Short-Term and Long-Term COVID-19 Complications. npj Digit. Med. 2021;4:117. doi: 10.1038/s41746-021-00484-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-021-00484-7</ArticleId><ArticleId IdType="pmc">PMC8316410</ArticleId><ArticleId IdType="pubmed">34315980</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of Long COVID Associated with Delta versus Omicron Variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>So M., Kabata H., Fukunaga K., Takagi H., Kuno T. Radiological and Functional Lung Sequelae of COVID-19: A Systematic Review and Meta-Analysis. BMC Pulm. Med. 2021;21:97. doi: 10.1186/s12890-021-01463-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-021-01463-0</ArticleId><ArticleId IdType="pmc">PMC7983097</ArticleId><ArticleId IdType="pubmed">33752639</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann A., Gysan M., Bernitzky D., Bal C., Prosch H., Zehetmayer S., Milos R.-I., Vonbank K., Pohl W., Idzko M., et al. Comparison of Pulmonary Function Test, Diffusion Capacity, Blood Gas Analysis and CT Scan in Patients with and without Persistent Respiratory Symptoms Following COVID-19. BMC Pulm. Med. 2022;22:196. doi: 10.1186/s12890-022-01987-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-022-01987-z</ArticleId><ArticleId IdType="pmc">PMC9109200</ArticleId><ArticleId IdType="pubmed">35578190</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahid A., Wilkinson K., Marcu S., Shapiro C.M. Fatigue Severity Scale (FSS) In: Shahid A., Wilkinson K., Marcu S., Shapiro C.M., editors. STOP, THAT and One Hundred Other Sleep Scales. Springer; New York, NY, USA: 2011. pp. 167&#x2013;168.</Citation></Reference><Reference><Citation>Bedree H., Sunnquist M., Jason L.A. The DePaul Symptom Questionnaire-2: A Validation Study. Fatigue Biomed. Health Behav. 2019;7:166&#x2013;179. doi: 10.1080/21641846.2019.1653471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2019.1653471</ArticleId><ArticleId IdType="pmc">PMC7367506</ArticleId><ArticleId IdType="pubmed">32685281</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourmistrova N.W., Solomon T., Braude P., Strawbridge R., Carter B. Long-Term Effects of COVID-19 on Mental Health: A Systematic Review. J. Affect. Disord. 2022;299:118&#x2013;125. doi: 10.1016/j.jad.2021.11.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.11.031</ArticleId><ArticleId IdType="pmc">PMC8758130</ArticleId><ArticleId IdType="pubmed">34798148</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern A.F. The Hospital Anxiety and Depression Scale. Occup. Med. 2014;64:393&#x2013;394. doi: 10.1093/occmed/kqu024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqu024</ArticleId><ArticleId IdType="pubmed">25005549</ArticleId></ArticleIdList></Reference><Reference><Citation>Post M.W.M., van der Zee C.H., Hennink J., Schafrat C.G., Visser-Meily J.M.A., van Berlekom S.B. Validity of the Utrecht Scale for Evaluation of Rehabilitation-Participation. Disabil. Rehabil. 2012;34:478&#x2013;485. doi: 10.3109/09638288.2011.608148.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09638288.2011.608148</ArticleId><ArticleId IdType="pubmed">21978031</ArticleId></ArticleIdList></Reference><Reference><Citation>van Hout B., Janssen M.F., Feng Y.-S., Kohlmann T., Busschbach J., Golicki D., Lloyd A., Scalone L., Kind P., Pickard A.S. Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets. Value Health. 2012;15:708&#x2013;715. doi: 10.1016/j.jval.2012.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2012.02.008</ArticleId><ArticleId IdType="pubmed">22867780</ArticleId></ArticleIdList></Reference><Reference><Citation>Hays R.D., Bjorner J.B., Revicki D.A., Spritzer K.L., Cella D. Development of Physical and Mental Health Summary Scores from the Patient-Reported Outcomes Measurement Information System (PROMIS) Global Items. Qual. Life Res. 2009;18:873&#x2013;880. doi: 10.1007/s11136-009-9496-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-009-9496-9</ArticleId><ArticleId IdType="pmc">PMC2724630</ArticleId><ArticleId IdType="pubmed">19543809</ArticleId></ArticleIdList></Reference><Reference><Citation>Prins A., Bovin M.J., Smolenski D.J., Marx B.P., Kimerling R., Jenkins-Guarnieri M.A., Kaloupek D.G., Schnurr P.P., Kaiser A.P., Leyva Y.E., et al. The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): Development and Evaluation Within a Veteran Primary Care Sample. J. Gen. Intern. Med. 2016;31:1206&#x2013;1211. doi: 10.1007/s11606-016-3703-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-016-3703-5</ArticleId><ArticleId IdType="pmc">PMC5023594</ArticleId><ArticleId IdType="pubmed">27170304</ArticleId></ArticleIdList></Reference><Reference><Citation>Murcia J.a.M., Gimeno E.C., Camacho A.M. Measuring Self-Determination Motivation in a Physical Fitness Setting: Validation of the Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2) in a Spanish Sample. J. Sport. Med. Phys. Fit. 2007;47:366&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pubmed">17641607</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelletier L.G., Dion S.C., Slovinec-D&#x2019;Angelo M., Reid R. Why Do You Regulate What You Eat? Relationships Between Forms of Regulation, Eating Behaviors, Sustained Dietary Behavior Change, and Psychological Adjustment. Motiv. Emot. 2004;28:245&#x2013;277. doi: 10.1023/B:MOEM.0000040154.40922.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:MOEM.0000040154.40922.14</ArticleId></ArticleIdList></Reference><Reference><Citation>SODAQ  SODAQ Snifferbike&#x2014;SODAQ.  [(accessed on 6 June 2022)].  Available online:  https://old.sodaq.com/sodaq-snifferbike/</Citation></Reference><Reference><Citation>O&#x2019;Connell S.G., Kincl L.D., Anderson K.A. Silicone Wristbands as Personal Passive Samplers. Environ. Sci. Technol. 2014;48:3327&#x2013;3335. doi: 10.1021/es405022f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/es405022f</ArticleId><ArticleId IdType="pmc">PMC3962070</ArticleId><ArticleId IdType="pubmed">24548134</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Bool C., Rutten E.P.A., van Helvoort A., Franssen F.M.E., Wouters E.F.M., Schols A.M.W.J. A Randomized Clinical Trial Investigating the Efficacy of Targeted Nutrition as Adjunct to Exercise Training in COPD: Targeted Nutrition in COPD Patients with Low Muscle Mass. J. Cachexia Sarcopenia Muscle. 2017;8:748&#x2013;758. doi: 10.1002/jcsm.12219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12219</ArticleId><ArticleId IdType="pmc">PMC5659064</ArticleId><ArticleId IdType="pubmed">28608438</ArticleId></ArticleIdList></Reference><Reference><Citation>van Beers M., Rutten-van M&#xf6;lken M.P.M.H., van de Bool C., Boland M., Kremers S.P.J., Franssen F.M.E., van Helvoort A., Gosker H.R., Wouters E.F., Schols A.M.W.J. Clinical Outcome and Cost-Effectiveness of a 1-Year Nutritional Intervention Programme in COPD Patients with Low Muscle Mass: The Randomized Controlled NUTRAIN Trial. Clin. Nutr. 2020;39:405&#x2013;413. doi: 10.1016/j.clnu.2019.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2019.03.001</ArticleId><ArticleId IdType="pubmed">30954363</ArticleId></ArticleIdList></Reference><Reference><Citation>Laviano A., Calder P.C., Schols A., Lonnqvist F., Bech M., Dorkhan M., Muscaritoli M. Targeted Medical Nutrition in Pre-Cachectic Patients with Non-Small-Cell Lung Cancer: A Subgroup Analysis. Nutr. Cancer. 2021;73:899&#x2013;900. doi: 10.1080/01635581.2020.1773873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01635581.2020.1773873</ArticleId><ArticleId IdType="pubmed">32519909</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder P.C., Laviano A., Lonnqvist F., Muscaritoli M., &#xd6;hlander M., Schols A. Targeted Medical Nutrition for Cachexia in Chronic Obstructive Pulmonary Disease: A Randomized, Controlled Trial: Cachexia in COPD: TMN RCT. J. Cachexia Sarcopenia Muscle. 2018;9:28&#x2013;40. doi: 10.1002/jcsm.12228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12228</ArticleId><ArticleId IdType="pmc">PMC5803606</ArticleId><ArticleId IdType="pubmed">28891198</ArticleId></ArticleIdList></Reference><Reference><Citation>Laviano A., Calder P.C., Schols A.M.W.J., Lonnqvist F., Bech M., Muscaritoli M. Safety and Tolerability of Targeted Medical Nutrition for Cachexia in Non-Small-Cell Lung Cancer: A Randomized, Double-Blind, Controlled Pilot Trial. Nutr. Cancer. 2020;72:439&#x2013;450. doi: 10.1080/01635581.2019.1634746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01635581.2019.1634746</ArticleId><ArticleId IdType="pubmed">31290697</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen G.L., Cederholm T., Correia M.I.T.D., Gonzalez M.C., Fukushima R., Higashiguchi T., Baptista G.A., Barazzoni R., Blaauw R., Coats A.J.S., et al. GLIM Criteria for the Diagnosis of Malnutrition: A Consensus Report From the Global Clinical Nutrition Community. J. Parenter. Enter. Nutr. 2019;43:32&#x2013;40. doi: 10.1002/jpen.1440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jpen.1440</ArticleId><ArticleId IdType="pubmed">30175461</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>